Pharma PLM sales will expand through 2036, with Lipitor holding 32.2% of the product type segment in 2026, driven by demand for specialized lipitor applications. The market was valued at USD 435.70 million in 2025 and is expected to be worth USD 1.49 billion by 2036, creating an incremental opportunity of USD 998.99 million.